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INTRODUCTION {#ajmga37883-sec-0002}
============

Gastroschisis is an abdominal wall defect that is present at birth where a portion of the intestines protrudes outside of the body. The defect most likely occurs between the 5th and 8th week gestation and the pathogenesis is largely unknown. This congenital anomaly affects approximately 4.5 infants per 10,000 U.S. live births \[Parker et al., [2010](#ajmga37883-bib-0018){ref-type="ref"}\]. The most consistently observed risk factor is maternal age of \<20 years \[Rasmussen and Frias, [2008](#ajmga37883-bib-0019){ref-type="ref"}; Vu et al., [2008](#ajmga37883-bib-0025){ref-type="ref"}\].

Gastroschisis frequency has been inexplicably increasing around the world for several decades \[Castilla et al., [2008](#ajmga37883-bib-0005){ref-type="ref"}\]. Several studies of familial cases of gastroschisis have suggested an underlying genetic susceptibility for gastroschisis \[Torfs et al., [1996](#ajmga37883-bib-0024){ref-type="ref"}; Kohl et al., [2010](#ajmga37883-bib-0013){ref-type="ref"}; Feldkamp et al., [2011](#ajmga37883-bib-0008){ref-type="ref"}\]. However, given the recent increase in frequency, it is not likely that genetic variants are solely responsible for the occurrence of gastroschisis. We hypothesize that gene variants in conjunction with additional exposures or covariates may increase the risk of gastroschisis.

There have been four studies of gene variants and gastroschisis over the past 10 years \[Cardonick et al., [2005](#ajmga37883-bib-0004){ref-type="ref"}; Torfs et al., [2006](#ajmga37883-bib-0023){ref-type="ref"}; Feldkamp et al., [2012](#ajmga37883-bib-0007){ref-type="ref"}; Jenkins et al., [2014](#ajmga37883-bib-0012){ref-type="ref"}\]. One investigated polymorphisms in 32 genes (representing enzymes involved in angiogenesis, blood vessel integrity, inflammation, wound repair, and dermal or epidermal strength) in a case‐control study of 57 cases of gastroschisis and 506 controls \[Torfs et al., [2006](#ajmga37883-bib-0023){ref-type="ref"}\]. This study found that gene variants that have been implicated with blood pressure regulation and cell--cell interaction were associated with an increased risk for a gastroschisis for heterozygotes\[Torfs et al., [2006](#ajmga37883-bib-0023){ref-type="ref"}\]. Some variants showed a strong interaction with maternal smoking, which supports the hypothesis of a vascular compromise as part of a multifactorial etiology of gastroschisis involving both genes and environmental factors \[Torfs et al., [2006](#ajmga37883-bib-0023){ref-type="ref"}\]. A second study found no association between variants in *MTHFR*, a gene related to homocysteine metabolism, and gastroschisis in 31 cases and 52 controls \[Cardonick et al., [2005](#ajmga37883-bib-0004){ref-type="ref"}\]. An additional study found no association between gastroschisis and *AEBP1* variants, a gene that encodes an intracellular protein involved in pro‐inflammatory processes \[Feldkamp et al., [2012](#ajmga37883-bib-0007){ref-type="ref"}\]. The fourth study did not find consistent associations between variants of three genes that code for enzymes involved in metabolism of some cigarette smoke consitituents, *CYP1A1*, *CYP1A2*, and *NAT2*, nor effect modification with maternal smoking, and risk of gastroschisis \[Jenkins et al., [2014](#ajmga37883-bib-0012){ref-type="ref"}\].

To extend this relatively small body of work, in a population‐based case‐control study, we investigated 75 genetic variants in 20 genes and risk of gastroschisis with regard to maternal age, race/ethnicity, vitamin use, and smoking exposure. Many of these genes and variants were also examined in the previous study by Torfs et al. \[[2006](#ajmga37883-bib-0023){ref-type="ref"}\], but this study includes different cases and controls than those investigated in that study. We hypothesized that genes related to vascular compromise may interact with these factors to affect the risk of gastroschisis. For this reason, we chose genes with the following patho‐genetic groupings: homocysteine metabolism, blood pressure regulation, coagulation, cell--cell interaction, and inflammatory response.

METHODS {#ajmga37883-sec-0003}
=======

Study Population {#ajmga37883-sec-0004}
----------------

The California Center of the National Birth Defects Prevention Study \[Yoon et al., [2001](#ajmga37883-bib-0026){ref-type="ref"}; Reefhuis et al., [2015](#ajmga37883-bib-0021){ref-type="ref"}\] is a collaborative partnership between Stanford University and the California Birth Defects Monitoring Program in the Department of Public Health. Since 1997, the Center has been collecting data from women whose residence at the time of delivery was in one of eight counties in the San Joaquin Valley. The California Birth Defects Monitoring Program is a surveillance program that is population‐based \[Croen et al., [1991](#ajmga37883-bib-0006){ref-type="ref"}\].

To identify cases with birth defects, data collection staff visit all hospitals with obstetric or pediatric services, cytogenetic laboratories, and all clinical genetics prenatal and postnatal outpatient services. Cases included infants or fetuses with gastroschisis confirmed by clinical geneticists based on clinical, surgical, or autopsy reports. Cases recognized or strongly suspected to have single‐gene conditions or chromosomal abnormalities or with identifiable syndromes were ineligible \[Rasmussen et al., [2003](#ajmga37883-bib-0020){ref-type="ref"}\], given their presumed distinct underlying etiology. Controls included non‐malformed live‐born infants randomly selected from birth hospitals to represent the population from which the cases were selected. The current analysis included 79 gastroschisis cases and 149 controls with estimated dates of delivery from October 1, 1997, to December 31, 2001 in the California Center of the National Birth Defects Prevention Study.

Maternal interviews were conducted using a standardized, computer‐based questionnaire, by telephone, in English or Spanish, between six weeks and 24 months after the infant\'s estimated date of delivery. Interviews were conducted with mothers of 80% of eligible cases (n = 63) and 71% of controls (n = 106).

Genotyping {#ajmga37883-sec-0005}
----------

Prior to leaving the hospital, a few drops of blood from the newborn\'s heel are collected on filter paper as part of the California newborn screening program. Genomic DNA was extracted from infant dried bloodspots using MasterPure™ Complete DNA and RNA Purification Kit (Epicenter Biotechnologies Madison, WI) and 10 ng genomic DNA was then used for whole genome amplification (WGA) using Qiagen\'s (Repli‐g®) amplification kit, which utilizes a technique called Multiple Displacement Amplification. This provides unbiased and accurate amplification of whole genomes.

For SNP genotyping, multiplexed genotyping assays were developed utilizing a high throughput platform, the Sequenom MALDI‐TOF Mass Array System. This protocol requires 5--10 ng of WGA DNA. The assay consists of an initial locus‐specific PCR reaction, followed by single base extension using mass‐modified dideoxynucleotide terminators of an oligonucleotide primer which anneals immediately upstream of the polymorphic site of interest. Using MALDI‐TOF mass spectrometry, the distinct mass of the extended primer identifies the SNP allele. (Primer sequences and reaction conditions are available upon request). Some genotyping was also done using polymerase chain reaction (PCR) endpoint analysis.

All genotyping was performed blinded to case and control status.

Statistical Analysis {#ajmga37883-sec-0006}
--------------------

For each gene variant, the Haploview Program (version 4.2, [http://www. broadinstitute.org/scientific-community/science/programs/medical- and-population-genetics/haploview/haploview](http://www.broadinstitute.org/scientific-community/science/programs/medical-and-population-genetics/haploview/haploview)) \[Barrett et al., [2005](#ajmga37883-bib-0003){ref-type="ref"}\] was used to calculate minor allele frequency (MAF) and to evaluate deviations from Hardy--Weinberg equilibrium (HWE) among controls. These analyses were conducted for all participants together and separately for native‐born Hispanic, foreign‐born Hispanic, and non‐Hispanic white mothers.

Of the 82 gene variants that were genotyped, five were excluded due to small sample size with both heterozygosity and homozygosity variants less than three (*SCNN1A* rs5742912, *F2* rs1799963, *F5* rs6025, *TNF* rs1800750, *TNF* rs673) among cases or controls, separately. One gene variant (ICAM5 rs892188) was excluded because it failed the HWE test (*P*‐value \<0.001, default setting in Haploview) among all controls and among controls in each race/ethnicity group. An additional four SNPs (rs281419, rs281439, rs3093030, rs699) failed HWE among all controls, but remained in the analysis because they did fit HWE expectations when stratified by race/ethnicity. Lastly, GSTT and GSTM were combined for analysis.

Risk for gastroschisis associated with each gene variant was calculated for both the homozygotes and the heterozygotes, with the homozygous wildtypes as the referent. For all gene variants, the wild‐type/reference genotype was defined as the homozygous genotype with the most frequent allele among controls. Risks were estimated as odds ratios (ORs) with 95% confidence intervals (CIs) by logistic regression using SAS software (version 9.4, SAS Institute, Cary, NC). Regression analyses were stratified by maternal race/ethnicity, age, vitamin use, and smoking status during the periconceptional period (one month prior to conception through the second month of pregnancy). Wald chi‐square tests were calculated for the interaction terms to determine if the subgroups were statistically different.

Haplotypes were constructed for 75 gene variants using the HaploView program (<https://www.broadinstitute.org/scientific-community/science/programs/medical-and-population-genetics/haploview/haploview>). The OR of each haplotype was calculated using the sum of all other haplotypes as reference.

RESULTS {#ajmga37883-sec-0007}
=======

The final study population included 228 individuals, 20 genes with 75 gene variants.

Demographic characteristics of cases and controls are presented in Table [I](#ajmga37883-tbl-0001){ref-type="table-wrap"}. The subset of interviewed participants are in the second column. The study population was mostly Hispanic, though more cases are U.S.‐born and more controls are foreign‐born. Additionally, the cases are younger than controls, as expected given the increased risk for gastroschisis among young mothers.

###### 

Demographic Characteristics of Gastroschisis Cases and Non‐Malformed Controls, California 1997--2001

                                                                 All participants (n = 228)   Interviewed participants (n = 169)                
  -------------------------------------------------------------- ---------------------------- ------------------------------------ ------------ ------------
  Maternal race/ethnicity                                                                                                                       
  White                                                          30 (38.0)                    52 (34.9)                            21 (33.3)    43 (40.6)
  U.S.‐born Hispanic                                             21 (26.6)                    27 (18.1)                            19 (30.2)    19 (17.9)
  Foreign‐born Hispanic                                          19 (24.1)                    43 (28.9)                            15 (23.8)    34 (32.1)
  Other                                                          9 (11.4)                     23 (15.4)                            8 (12.7)     8 (7.5)
  Maternal age at delivery (years)                                                                                                              
  \<20                                                           36 (45.6)                    22 (14.8)                            30 (47.6)    13 (12.3)
  20--24                                                         26 (32.9)                    42 (28.2)                            19 (30.2)    31 (29.2)
  \>25                                                           17 (21.5)                    81 (54.4)                            14 (22.2)    60 (56.6)
  Maternal education (years)                                                                                                                    
  \<12                                                           38 (48.1)                    45 (30.2)                            28 (44.4)    31 (29.2)
  12                                                             28 (35.4)                    56 (37.6)                            25 (39.7)    37 (34.9)
  \>12                                                           11 (13.9)                    42 (28.2)                            9 (14.3)     36 (34.0)
  Parity                                                                                                                                        
  0                                                              53 (67.1)                    44 (29.5)                            44 (69.8)    34 (32.1)
  1+                                                             26 (32.9)                    101 (67.8)                           19 (30.2)    70 (66.0)
  Plurality                                                                                                                                     
  Singletons                                                     79 (100.0)                   143 (96.0)                           63 (100.0)   103 (97.2)
  Infant sex                                                                                                                                    
  Male                                                           45 (57.0)                    74 (49.7)                            34 (54.0)    52 (49.1)
  Female                                                         34 (43.0)                    71 (47.7)                            29 (46.0)    52 (49.1)
  Multi‐vitamin Use[^b^](#ajmga37883-note-0003){ref-type="fn"}                                                                                  
  No                                                             N/A                          N/A                                  27 (42.9)    37 (34.9)
  Yes                                                            N/A                          N/A                                  35 (55.6)    69 (65.1)
  Smoking[^b^](#ajmga37883-note-0003){ref-type="fn"}                                                                                            
  None                                                           N/A                          N/A                                  50 (79.4)    90 (84.9)
  Any                                                            N/A                          N/A                                  12 (19.0)    15 (14.2)

N/A not applicable because interview was not conducted.

Percentages may not equal 100 owing to rounding and missing.

During the month before or the first 2 months of pregnancy.

© 2016 Wiley Periodicals, Inc.

Table [II](#ajmga37883-tbl-0002){ref-type="table-wrap"} lists the position of the gene variants and summarizes the call rates and MAFs and HWE evaluation using the HaploView Program.

###### 

Characteristics of Gene Variants Among All Racial/Ethnic Groups, California 1997--2001, HWE Evaluated Using HaploView Program

  Gene Symbol               dbSNP ID     Position    Reference Allele[^a^](#ajmga37883-note-0005){ref-type="fn"}   Call rate %   MAF[^b^](#ajmga37883-note-0006){ref-type="fn"}   HWE P[^b^](#ajmga37883-note-0006){ref-type="fn"}
  ------------------------- ------------ ----------- ------------------------------------------------------------- ------------- ------------------------------------------------ --------------------------------------------------
  Homocysteine metabolism                                                                                                                                                         
  MTHFR                     rs1801133    11796321    C                                                             97.8          0.35                                             0.421
  Blood pressure                                                                                                                                                                  
  NOS3                      rs1036145    150112078   A                                                             96.5          0.29                                             0.089
  NOS3                      rs2373962    150118625   G                                                             96.9          0.23                                             0.185
  NOS3                      rs6951150    150119562   C                                                             78.9          0.22                                             0.031
  NOS3                      rs10277237   150120992   G                                                             83.8          0.38                                             0.113
  NOS3                      rs1800783    150127045   T                                                             100           0.25                                             0.528
  NOS3                      rs12703107   150683629   G                                                             93.9          0.42                                             0.072
  NOS3                      rs4496877    150983418   G                                                             99.1          0.24                                             1.000
  NOS3                      rs1800779    150992855   A                                                             97.8          0.21                                             0.169
  NOS3                      rs3918226    150993088   C                                                             96.1          0.04                                             1.000
  NOS3                      rs1799983    150999023   G                                                             98.2          0.22                                             0.250
  NOS3                      rs3918227    151003858   C                                                             94.7          0.05                                             0.002
  NOS3                      rs3918188    151005693   C                                                             97.4          0.29                                             0.759
  NOS3                      rs743507     151010400   G                                                             99.6          0.18                                             0.357
  AGTR1                     rs5186       148742201   A                                                             98.2          0.31                                             0.271
  AGT                       rs699        230710048   T                                                             95.2          0.37                                             \<0.001
  NPPA                      rs198358     11838342    G                                                             91.7          0.19                                             0.001
  NPPA                      rs198361     11839899    C                                                             95.6          0.09                                             1.000
  NPPA                      rs5067       11840247    A                                                             100           0.12                                             0.643
  NPPA                      rs198372     11843780    A                                                             100           0.07                                             1.000
  NPPA                      rs198373     11843801    A                                                             97.8          0.09                                             1.000
  NPPA                      rs632793     11844943    G                                                             99.1          0.27                                             0.200
  NPPA                      rs5065       11846011    T                                                             98.2          0.13                                             1.000
  NPPA                      rs5063       11847591    G                                                             96.9          0.06                                             0.176
  ADD1                      rs735794     2809236     C                                                             90.4          0.47                                             0.262
  ADD1                      rs4690002    2841240     T                                                             100           0.36                                             0.117
  ADD1                      rs12503220   2850142     G                                                             99.6          0.17                                             0.001
  ADD1                      rs1877723    2883805     G                                                             91.2          0.22                                             0.547
  ADD1                      rs3775068    2888441     T                                                             99.1          0.47                                             0.114
  ADD1                      rs10026792   2899196     G                                                             97.4          0.18                                             0.162
  ADD1                      rs4961       2904980     G                                                             96.9          0.18                                             1.000
  ADD1                      rs16843523   2915080     C                                                             92.5          0.17                                             0.139
  ADD1                      rs1263359    2925576     C                                                             97.4          0.43                                             0.057
  ADD1                      rs3775067    2925628     C                                                             93.4          0.48                                             0.011
  ADD1                      rs7678161    2938608     C                                                             78.9          0.31                                             0.004
  ADD1                      rs2285084    2943293     C                                                             100           0.21                                             0.059
  ADD1                      rs762847     2949071     C                                                             95.2          0.44                                             0.003
  SCNN1A                    rs2228576    6327323     G                                                             95.6          0.29                                             0.905
  GNB3                      rs5443       6845711     C                                                             96.1          0.38                                             0.337
  ADRB2                     rs1042713    148826877   A                                                             96.1          0.48                                             0.233
  ADRB2                     rs1042714    148826910   C                                                             95.6          0.18                                             0.034
  Coagulation                                                                                                                                                                     
  F7                        rs5742910    113105517   Deletion                                                      98.2          0.14                                             1.000
  F7                        rs6064       113118845   G                                                             94.3          0.11                                             1.000
  SERPINE1                  rs2227684    100776931   G                                                             97.8          0.36                                             0.302
  FGB                       rs1799768    100785547   G                                                             97.8          0.17                                             0.323
  SERPINE1                  rs1799889    101126430   G                                                             97.8          0.41                                             0.636
  Cell--cell interaction                                                                                                                                                          
  ITGA2                     rs1062535    52351413    G                                                             98.2          0.37                                             0.180
  ITGB3                     rs5918       45360730    T                                                             98.2          0.10                                             0.756
  SELE                      rs5355       169726729   C                                                             98.2          0.04                                             1.000
  SELE                      rs5361       169731919   A                                                             98.2          0.05                                             0.063
  ICAM1                     rs1059840    10231490    A                                                             95.2          0.15                                             0.431
  ICAM1                     rs11115      10231542    C                                                             96.5          0.41                                             0.193
  ICAM1                     rs1059849    10231654    A                                                             97.8          0.43                                             0.221
  ICAM1                     rs281428     10249324    T                                                             99.6          0.23                                             0.101
  ICAM5                     rs2075741    10258238    C                                                             96.1          0.44                                             0.003
  ICAM5                     rs2569702    10264947    T                                                             100           0.50                                             0.151
  ICAM5                     rs2291473    10276781    C                                                             95.2          0.09                                             0.561
  ICAM5                     rs281419     10277842    G                                                             99.1          0.14                                             \<0.001
  ICAM1                     rs281432     10279982    C                                                             94.3          0.43                                             0.643
  ICAM5                     rs281417     10280130    T                                                             80.7          0.26                                             0.946
  ICAM1                     rs1799969    10284116    G                                                             97.4          0.15                                             0.033
  ICAM1                     rs3093030    10286727    C                                                             79.8          0.28                                             \<0.001
  ICAM5                     rs281439     10289434    C                                                             92.5          0.22                                             \<0.001
  ICAM1                     rs5030390    10382537    A                                                             100           0.03                                             1.000
  ICAM1                     rs3093032    10396335    C                                                             80.7          0.08                                             1.000
  ICAM4                     rs281438     10399375    G                                                             97.8          0.15                                             0.829
  ICAM5                     rs281440     10400304    A                                                             78.5          0.28                                             0.499
  ICAM5                     rs2228615    10403368    A                                                             92.1          0.49                                             0.041
  ICAM5                     rs892188     10409793    C                                                             95.2          0.41                                             \<0.001
  Inflammatory response                                                                                                                                                           
  LTA                       rs1041981    31573007    C                                                             98.2          0.33                                             0.464
  TNF                       rs1800629    31575254    G                                                             98.2          0.09                                             1.000
  TNF                       rs361525     31575324    G                                                             96.1          0.05                                             0.496
  MMP3                      rs35068180   2845216     A                                                             97.8          0.36                                             0.752
  GSTT1                     rs1234       1234        Absent                                                        99.6          0.17                                             NA
  GSTM1                     rs5678       5678        Absent                                                        99.6          0.37                                             NA
  NAT1                                   1088        T                                                             98.2          0.38                                             0.078

NA not applicable (patterns are absent/present and HWE *P*‐value is not available).

Determined by most frequent allele among controls.

Among controls (N = 149).

© 2016 Wiley Periodicals, Inc.

The results of the regression analyses in the entire population are in Supplemental Material Table [I](#ajmga37883-tbl-0001){ref-type="table-wrap"}. Overall, 132 ORs were calculated. There were an additional 21 estimates that were not calculated because they did not meet our criteria which required at least three individuals in each cell. We observed 12 ORs with 95% CIs that excluded 1.0: 6 gene variants were associated with increased risk and three with decreased risk of gastroschisis for both heterozygous (OR~h~) and homozygous (OR~v~) variants. These included *NOS3* (rs1036145) OR~h~ = 0.4 (95% CI: 0.2--0.7); *NOS3* (rs10277237) OR~v~ = 2.7 (95% CI: 1.3--6.0); *ADD1* (rs12503220) OR~h~ = 2.9 (95% CI: 1.6--5.4), *GNB3* (rs5443) OR~h~ = 0.2 (95% CI: 0.1--0.5), OR~v~ = 0.4 (95% CI: 0.2--0.9); *ICAM1* (rs281428) OR~v~ = 6.9 (95% CI: 2.1--22.9), *ICAM1* (rs3093030) OR~v~ =2.6 (95% CI: 1.2--5.6); *ICAM4* (rs281438) OR~v~ = 4.9 (95% CI: 1.4--16.6), *ICAM5* (rs281417) OR~h~ = 2.1 (95% CI: 1.1--4.1), OR~v~ = 4.8 (95% CI: 1.7--13.6); *ICAM5* (rs2075741) OR~v~ = 2.2 (95% CI: 1.1--4.4); *NAT1* OR~v~ = 0.3 (95% CI: 0.1--0.9).

Results of gene variant analyses stratified by maternal race/ethnicity, age at delivery, vitamin use and smoking in early pregnancy are shown in Table [III](#ajmga37883-tbl-0003){ref-type="table-wrap"}. No statistically significant differences were observed between gene variants and risk of gastroschisis among the various race/ethnic groups. We observed gene variant risks of gastroschisis that differed between these subgroups. Among women aged 20--24, there were increased risks of gastroschisis associated with the following heterozygous gene variants: *NOS3* (rs1800779)*, NOS3* (rs2373962), *NOS3* (rs4496877), and *NOS3* (rs6951150). Among women aged 25+ homozygous variants of ADD1 (rs2285084) were associated with increased risk of gastroschisis.

###### 

Associations Between Gene Variants and Risk of Gastroschisis Stratified by Selected Maternal Demographics and Exposures, California 1997--2001

  Gene Symbol      dbSNP ID     Subgroup         Genotype    Case N   Control N   OR (95% CI)
  ---------------- ------------ ---------------- ----------- -------- ----------- --------------------------
  Race/ethnicity                                                                  
  MTHFR            rs1801133    White NH         Wildtype    10       20          Reference
  MTHFR            rs1801133    White NH         Hetero      16       27          1.2 (0.4--3.2)
  MTHFR            rs1801133    White NH         Variant     3        5           1.2 (0.2--6.1)
  MTHFR            rs1801133    NB Hispanic      Wildtype    3        15          Reference
  MTHFR            rs1801133    NB Hispanic      Hetero      13       8           **8.1 (1.8--37.2)**
  MTHFR            rs1801133    NB Hispanic      Variant     3        3           5.0 (0.7--37.8)
  MTHFR            rs1801133    FB Hispanic      Wildtype    3        13          Reference
  MTHFR            rs1801133    FB Hispanic      Hetero      10       20          2.2 (0.5--9.4)
  MTHFR            rs1801133    FB Hispanic      Variant     6        10          2.6 (0.5--13.0)
  NOS3             rs1036145    White NH         Wildtype    15       19          Reference
  NOS3             rs1036145    White NH         Hetero      8        28          **0.4 (0.1--1.0)**
  NOS3             rs1036145    White NH         Variant     5        4           1.6 (0.4--6.9)
  NOS3             rs1036145    NB Hispanic      Wildtype    14       17          Reference
  NOS3             rs1036145    NB Hispanic      Hetero      5        6           1.0 (0.3--4.0)
  NOS3             rs1036145    NB Hispanic      Variant     1        1           NC
  NOS3             rs1036145    FB Hispanic      Wildtype    11       19          Reference
  NOS3             rs1036145    FB Hispanic      Hetero      4        23          0.3 (0.1--1.1)
  NOS3             rs1036145    FB Hispanic      Variant     4        1           NC
  NOS3             rs3918188    White NH         Wildtype    13       25          Reference
  NOS3             rs3918188    White NH         Hetero      11       19          1.1 (0.4--3.0)
  NOS3             rs3918188    White NH         Variant     5        7           1.4 (0.4--5.2)
  NOS3             rs3918188    NB Hispanic      Wildtype    14       17          Reference
  NOS3             rs3918188    NB Hispanic      Hetero      5        8           0.8 (0.2--2.8)
  NOS3             rs3918188    NB Hispanic      Variant     1        0           NC
  NOS3             rs3918188    FB Hispanic      Wildtype    5        25          Reference
  NOS3             rs3918188    FB Hispanic      Hetero      11       17          **3.2 (1.0--11.0)**
  NOS3             rs3918188    FB Hispanic      Variant     3        1           NC
  AGT              rs699        White NH         Wildtype    6        12          Reference
  AGT              rs699        White NH         Hetero      17       25          1.4 (0.4--4.3)
  AGT              rs699        White NH         Variant     4        14          0.6 (0.1--2.5)
  AGT              rs699        NB Hispanic      Wildtype    8        11          Reference
  AGT              rs699        NB Hispanic      Hetero      8        11          1.0 (0.3--3.6)
  AGT              rs699        NB Hispanic      Variant     4        3           1.8 (0.3--10.6)
  AGT              rs699        FB Hispanic      Wildtype    7        24          Reference
  AGT              rs699        FB Hispanic      Hetero      8        6           **4.6 (1.2--17.7)**
  AGT              rs699        FB Hispanic      Variant     4        11          1.2 (0.3--5.2)
  ADD1             rs12503220   White NH         Wildtype    19       41          Reference
  ADD1             rs12503220   White NH         Hetero      10       8           2.7 (0.9--7.9)
  ADD1             rs12503220   White NH         Variant     1        3           NC
  ADD1             rs12503220   NB Hispanic      Wildtype    7        17          Reference
  ADD1             rs12503220   NB Hispanic      Hetero      12       7           **4.2 (1.2--15.0)**
  ADD1             rs12503220   NB Hispanic      Variant     2        2           NC
  ADD1             rs12503220   FB Hispanic      Wildtype    10       32          Reference
  ADD1             rs12503220   FB Hispanic      Hetero      6        7           2.7 (0.7--10.1)
  ADD1             rs12503220   FB Hispanic      Variant     3        4           2.4 (0.5--12.6)
  GNB3             Rs5443       White NH         Wildtype    22       28          Reference
  GNB3             Rs5443       White NH         Hetero      5        18          0.4 (0.1--1.1)
  GNB3             Rs5443       White NH         Variant     2        5           NC
  GNB3             Rs5443       NB Hispanic      Wildtype    14       9           Reference
  GNB3             Rs5443       NB Hispanic      Hetero      4        13          **0.2 (0.0--0.8)**
  GNB3             Rs5443       NB Hispanic      Variant     2        3           NC
  GNB3             Rs5443       FB Hispanic      Wildtype    13       17          Reference
  GNB3             Rs5443       FB Hispanic      Hetero      4        15          0.3 (0.1--1.3)
  GNB3             Rs5443       FB Hispanic      Variant     2        10          NC
  SERPINE1         rs1799889    White NH         Wildtype    10       8           Reference
  SERPINE1         rs1799889    White NH         Hetero      15       27          0.4 (0.1--1.4)
  SERPINE1         rs1799889    White NH         Variant     4        16          **0.2 (0.0--0.8)**
  SERPINE1         rs1799889    NB Hispanic      Wildtype    10       12          Reference
  SERPINE1         rs1799889    NB Hispanic      Hetero      9        10          1.1 (0.3--3.7)
  SERPINE1         rs1799889    NB Hispanic      Variant     1        4           NC
  SERPINE1         rs1799889    FB Hispanic      Wildtype    9        23          Reference
  SERPINE1         rs1799889    FB Hispanic      Hetero      7        17          1.1 (0.3--3.4)
  SERPINE1         rs1799889    FB Hispanic      Variant     3        3           2.6 (0.4--15.1)
  SELE             rs5361       White NH         Wildtype    21       46          Reference
  SELE             rs5361       White NH         Hetero      8        4           **4.4 (1.2--16.2)**
  SELE             rs5361       White NH         Variant     0        2           NC
  SELE             rs5361       NB Hispanic      Wildtype    19       26          Reference
  SELE             rs5361       NB Hispanic      Hetero      1        0           NC
  SELE             rs5361       NB Hispanic      Variant     0        0           NC
  SELE             rs5361       FB Hispanic      Wildtype    19       38          Reference
  SELE             rs5361       FB Hispanic      Hetero      0        5           NC
  SELE             rs5361       FB Hispanic      Variant     0        0           NC
  ICAM1            rs11115      White NH         Wildtype    12       24          Reference
  ICAM1            rs11115      White NH         Hetero      12       18          1.3 (0.5--3.6)
  ICAM1            rs11115      White NH         Variant     5        10          1.0 (0.3--3.6)
  ICAM1            rs11115      NB Hispanic      Wildtype    6        7           Reference
  ICAM1            rs11115      NB Hispanic      Hetero      10       13          NC
  ICAM1            rs11115      NB Hispanic      Variant     3        5           NC
  ICAM1            rs11115      FB Hispanic      Wildtype    1        14          Reference
  ICAM1            rs11115      FB Hispanic      Hetero      13       17          NC
  ICAM1            rs11115      FB Hispanic      Variant     4        11          NC
  ICAM1            rs3093030    White NH         Wildtype    9        24          Reference
  ICAM1            rs3093030    White NH         Hetero      8        10          2.1 (0.6--7.1)
  ICAM1            rs3093030    White NH         Variant     11       9           **3.3 (1.0--10.5)**
  ICAM1            rs3093030    NB Hispanic      Wildtype    13       12          Reference
  ICAM1            rs3093030    NB Hispanic      Hetero      3        5           0.6 (0.1--2.8)
  ICAM1            rs3093030    NB Hispanic      Variant     3        2           NC
  ICAM1            rs3093030    FB Hispanic      Wildtype    7        24          Reference
  ICAM1            rs3093030    FB Hispanic      Hetero      2        7           NC
  ICAM1            rs3093030    FB Hispanic      Variant     3        2           NC
  ICAM5            rs281440     White NH         Wildtype    2        22          Reference
  ICAM5            rs281440     White NH         Hetero      14       19          **8.1 (1.6--40.3)**
  ICAM5            rs281440     White NH         Variant     3        4           **8.2 (1.0--66.2)**
  ICAM5            rs281440     NB Hispanic      Wildtype    0        11          Reference
  ICAM5            rs281440     NB Hispanic      Hetero      13       9           NC
  ICAM5            rs281440     NB Hispanic      Variant     0        0           NC
  ICAM5            rs281440     FB Hispanic      Wildtype    0        18          Reference
  ICAM5            rs281440     FB Hispanic      Hetero      11       22          NC
  ICAM5            rs281440     FB Hispanic      Variant     1        1           NC
  ICAM5            rs2075741    White NH         Wildtype    6        13          Reference
  ICAM5            rs2075741    White NH         Hetero      8        23          0.8 (0.2--2.7)
  ICAM5            rs2075741    White NH         Variant     15       16          2.0 (0.6--6.7)
  ICAM5            rs2075741    NB Hispanic      Wildtype    7        13          Reference
  ICAM5            rs2075741    NB Hispanic      Hetero      9        6           2.8 (0.7--11.1)
  ICAM5            rs2075741    NB Hispanic      Variant     4        6           1.2 (0.3--5.9)
  ICAM5            rs2075741    FB Hispanic      Wildtype    6        23          Reference
  ICAM5            rs2075741    FB Hispanic      Hetero      6        14          1.6 (0.4--6.1)
  ICAM5            rs2075741    FB Hispanic      Variant     5        4           **4.8 (1.0--23.6)**
  ICAM5            rs2569702    White NH         Wildtype    16       16          Reference
  ICAM5            rs2569702    White NH         Hetero      10       28          **0.4 (0.1--1.0)**
  ICAM5            rs2569702    White NH         Variant     4        8           0.5 (0.1--2.0)
  ICAM5            rs2569702    NB Hispanic      Wildtype    5        8           Reference
  ICAM5            rs2569702    NB Hispanic      Hetero      11       10          1.8 (0.4--7.2)
  ICAM5            rs2569702    NB Hispanic      Variant     5        9           0.9 (0.2--4.2)
  ICAM5            rs2569702    FB Hispanic      Wildtype    5        9           Reference
  ICAM5            rs2569702    FB Hispanic      Hetero      8        16          0.9 (0.2--3.6)
  ICAM5            rs2569702    FB Hispanic      Variant     6        18          0.6 (0.1--2.5)
  Age                                                                             
  MTHFR            rs1801133    Age \<20         Wildtype    12       9           Reference
  MTHFR            rs1801133    Age \<20         Hetero      16       10          1.2 (0.4--3.9)
  MTHFR            rs1801133    Age \<20         Variant     7        2           NC
  MTHFR            rs1801133    Age 20--24       Wildtype    7        18          Reference
  MTHFR            rs1801133    Age 20--24       Hetero      12       15          2.1 (0.6--6.5)
  MTHFR            rs1801133    Age 20--24       Variant     5        9           1.4 (0.4--5.8)
  MTHFR            rs1801133    Age 25+          Wildtype    4        36          Reference
  MTHFR            rs1801133    Age 25+          Hetero      13       35          **3.3 (1.0--11.2)**
  MTHFR            rs1801133    Age 25+          Variant     0        9           NC
  NOS3             rs1800779    Age \<20         Wildtype    24       15          Reference
  NOS3             rs1800779    Age \<20         Hetero      10       3           2.1 (0.5--8.8)
  NOS3             rs1800779    Age \<20         Variant     1        3           NC
  NOS3             rs1800779    Age 20--24       Wildtype    10       32          Reference
  NOS3             rs1800779    Age 20--24       Hetero      10       9           **3.6 (1.1--11.2)**\*\*
  NOS3             rs1800779    Age 20--24       Variant     4        1           NC
  NOS3             rs1800779    Age 25+          Wildtype    11       45          Reference
  NOS3             rs1800779    Age 25+          Hetero      5        29          0.7 (0.2--2.2)
  NOS3             rs1800779    Age 25+          Variant     1        6           NC
  NOS3             rs2373962    Age \<20         Wildtype    25       13          Reference
  NOS3             rs2373962    Age \<20         Hetero      11       7           0.8 (0.3--2.6)
  NOS3             rs2373962    Age \<20         Variant     0        2           NC
  NOS3             rs2373962    Age 20--24       Wildtype    10       32          Reference
  NOS3             rs2373962    Age 20--24       Hetero      10       7           **4.6 (1.4--15.2)**\*\*
  NOS3             rs2373962    Age 20--24       Variant     4        2           NC
  NOS3             rs2373962    Age 25+          Wildtype    12       42          Reference
  NOS3             rs2373962    Age 25+          Hetero      3        29          0.4 (0.1--1.4)
  NOS3             rs2373962    Age 25+          Variant     1        7           NC
  NOS3             rs3918188    Age \<20         Wildtype    20       11          Reference
  NOS3             rs3918188    Age \<20         Hetero      14       8           1.0 (0.3--3.0)
  NOS3             rs3918188    Age \<20         Variant     0        3           NC
  NOS3             rs3918188    Age 20--24       Wildtype    13       19          Reference
  NOS3             rs3918188    Age 20--24       Hetero      9        15          0.9 (0.3--2.6)
  NOS3             rs3918188    Age 20--24       Variant     4        4           1.5 (0.3--6.9)
  NOS3             rs3918188    Age 25+          Wildtype    5        43          Reference
  NOS3             rs3918188    Age 25+          Hetero      7        32          1.9 (0.5--6.5)
  NOS3             rs3918188    Age 25+          Variant     5        6           **7.2 (1.6--32.3)**
  NOS3             rs4496877    Age \<20         Wildtype    24       13          Reference
  NOS3             rs4496877    Age \<20         Hetero      12       8           0.8 (0.3--2.5)
  NOS3             rs4496877    Age \<20         Variant     0        1           NC
  NOS3             rs4496877    Age 20--24       Wildtype    11       31          Reference
  NOS3             rs4496877    Age 20--24       Hetero      11       9           **3.4 (1.1--10.5)**\*\*
  NOS3             rs4496877    Age 20--24       Variant     3        1           NC
  NOS3             rs4496877    Age 25+          Wildtype    12       40          Reference
  NOS3             rs4496877    Age 25+          Hetero      4        35          0.4 (0.1--1.3)
  NOS3             rs4496877    Age 25+          Variant     1        6           NC
  NOS3             rs6951150    Age \<20         Wildtype    21       11          Reference
  NOS3             rs6951150    Age \<20         Hetero      9        6           0.8 (0.2--2.8)
  NOS3             rs6951150    Age \<20         Variant     0        2           NC
  NOS3             rs6951150    Age 20--24       Wildtype    10       26          Reference
  NOS3             rs6951150    Age 20--24       Hetero      10       6           **4.3 (1.2--15.1)**\*
  NOS3             rs6951150    Age 20--24       Variant     3        2           NC
  NOS3             rs6951150    Age 25+          Wildtype    10       35          Reference
  NOS3             rs6951150    Age 25+          Hetero      3        17          0.6 (0.2--2.5)
  NOS3             rs6951150    Age 25+          Variant     1        6           NC
  ADD1             rs2285084    Age \<20         Wildtype    26       13          Reference
  ADD1             rs2285084    Age \<20         Hetero      8        7           0.6 (0.2--1.9)
  ADD1             rs2285084    Age \<20         Variant     2        2           NC
  ADD1             rs2285084    Age 20--24       Wildtype    17       29          Reference
  ADD1             rs2285084    Age 20--24       Hetero      8        8           1.7 (0.5--5.4)
  ADD1             rs2285084    Age 20--24       Variant     1        5           NC
  ADD1             rs2285084    Age 25+          Wildtype    6        51          Reference
  ADD1             rs2285084    Age 25+          Hetero      8        26          2.6 (0.8--8.3)
  ADD1             rs2285084    Age 25+          Variant     3        4           **6.4 (1.1--35.6)**\*
  ADD1             rs7678161    Age \<20         Wildtype    13       11          Reference
  ADD1             rs7678161    Age \<20         Hetero      11       8           1.2 (0.3--3.9)
  ADD1             rs7678161    Age \<20         Variant     1        2           NC
  ADD1             rs7678161    Age 20--24       Wildtype    6        16          Reference
  ADD1             rs7678161    Age 20--24       Hetero      8        17          1.3 (0.4--4.4)
  ADD1             rs7678161    Age 20--24       Variant     1        1           NC
  ADD1             rs7678161    Age 25+          Wildtype    10       23          Reference
  ADD1             rs7678161    Age 25+          Hetero      5        42          **0.3 (0.1--0.9)**
  ADD1             rs7678161    Age 25+          Variant     0        2           NC
  ADD1             rs12503220   Age \<20         Wildtype    20       14          Reference
  ADD1             rs12503220   Age \<20         Hetero      12       5           1.7 (0.5--5.8)
  ADD1             rs12503220   Age \<20         Variant     4        3           0.9 (0.2--4.8)
  ADD1             rs12503220   Age 20--24       Wildtype    12       29          Reference
  ADD1             rs12503220   Age 20--24       Hetero      14       7           **4.8 (1.6--15.0)**
  ADD1             rs12503220   Age 20--24       Variant     0        5           NC
  ADD1             rs12503220   Age 25+          Wildtype    9        63          Reference
  ADD1             rs12503220   Age 25+          Hetero      6        15          2.8 (0.9--9.1)
  ADD1             rs12503220   Age 25+          Variant     2        3           NC
  ADD1             rs16843523   Age \<20         Wildtype    25       13          Reference
  ADD1             rs16843523   Age \<20         Hetero      7        6           0.6 (0.2--2.2)
  ADD1             rs16843523   Age \<20         Variant     3        2           NC
  ADD1             rs16843523   Age 20--24       Wildtype    17       29          Reference
  ADD1             rs16843523   Age 20--24       Hetero      6        8           1.3 (0.4--4.3)
  ADD1             rs16843523   Age 20--24       Variant     3        2           NC
  ADD1             rs16843523   Age 25+          Wildtype    8        50          Reference
  ADD1             rs16843523   Age 25+          Hetero      3        19          1.0 (0.2--4.1)
  ADD1             rs16843523   Age 25+          Variant     3        3           **6.3 (1.1--36.5)**
  GNB3             rs5443       Age \<20         Wildtype    25       6           Reference
  GNB3             rs5443       Age \<20         Hetero      7        8           **0.2 (0.1--0.8)**
  GNB3             rs5443       Age \<20         Variant     3        6           **0.1 (0.0--0.6)**
  GNB3             rs5443       Age 20--24       Wildtype    18       17          Reference
  GNB3             rs5443       Age 20--24       Hetero      3        17          **0.2 (0.0--0.7)**
  GNB3             rs5443       Age 20--24       Variant     4        7           0.5 (0.1--2.2)
  GNB3             rs5443       Age 25+          Wildtype    11       32          Reference
  GNB3             rs5443       Age 25+          Hetero      4        34          0.3 (0.1--1.2)
  GNB3             rs5443       Age 25+          Variant     2        11          NC
  ADRB2            rs1042714    Age \<20         Wildtype    26       17          Reference
  ADRB2            rs1042714    Age \<20         Hetero      6        4           1.0 (0.2--4.0)
  ADRB2            rs1042714    Age \<20         Variant     1        0           NC
  ADRB2            rs1042714    Age 20--24       Wildtype    20       23          Reference
  ADRB2            rs1042714    Age 20‐24        Hetero      3        14          **0.2 (0.1--1.0)**
  ADRB2            rs1042714    Age 20--24       Variant     1        4           NC
  ADRB2            rs1042714    Age 25+          Wildtype    14       58          Reference
  ADRB2            rs1042714    Age 25+          Hetero      2        16          NC
  ADRB2            rs1042714    Age 25+          Variant     0        5           NC
  ICAM1            rs281432     Age \<20         Wildtype    13       7           Reference
  ICAM1            rs281432     Age \<20         Hetero      12       8           0.8 (0.2--2.9)
  ICAM1            rs281432     Age \<20         Variant     10       4           1.3 (0.3--5.9)
  ICAM1            rs281432     Age 20--24       Wildtype    9        18          Reference
  ICAM1            rs281432     Age 20--24       Hetero      6        15          0.8 (0.2--2.8)
  ICAM1            rs281432     Age 20--24       Variant     9        7           2.6 (0.7--9.2)
  ICAM1            rs281432     Age 25+          Wildtype    9        22          Reference
  ICAM1            rs281432     Age 25+          Hetero      4        41          **0.2 (0.1--0.9)**
  ICAM1            rs281432     Age 25+          Variant     3        14          0.5 (0.1--2.3)
  ICAM1            rs1059849    Age \<20         Wildtype    13       5           Reference
  ICAM1            rs1059849    Age \<20         Hetero      13       9           0.6 (0.1--2.1)
  ICAM1            rs1059849    Age \<20         Variant     8        8           0.4 (0.1--1.6)
  ICAM1            rs1059849    Age 20--24       Wildtype    9        14          Reference
  ICAM1            rs1059849    Age 20--24       Hetero      10       16          1.0 (0.3--3.1)
  ICAM1            rs1059849    Age 20--24       Variant     7        12          0.9 (0.3--3.2)
  ICAM1            rs1059849    Age 25+          Wildtype    3        31          Reference
  ICAM1            rs1059849    Age 25+          Hetero      8        37          2.2 (0.5--9.2)
  ICAM1            rs1059849    Age 25+          Variant     5        11          **4.7 (1.0--23.0)**
  ICAM5            rs281440     Age \<20         Wildtype    1        13          Reference
  ICAM5            rs281440     Age \<20         Hetero      17       6           NC
  ICAM5            rs281440     Age \<20         Variant     3        1           NC
  ICAM5            rs281440     Age 20--24       Wildtype    1        11          Reference
  ICAM5            rs281440     Age 20--24       Hetero      16       20          NC
  ICAM5            rs281440     Age 20--24       Variant     0        3           NC
  ICAM5            rs281440     Age 25+          Wildtype    0        39          Reference
  ICAM5            rs281440     Age 25+          Hetero      8        31          NC
  ICAM5            rs281440     Age 25+          Variant     2        3           NC
  GSTT1 & GSTM1                 Age \<20         No Null     17       8           Reference
  GSTT1 & GSTM1                 Age \<20         Null in M   11       10          0.5 (0.2--1.7)
  GSTT1 & GSTM1                 Age \<20         Null in T   3        1           NC
  GSTT1 & GSTM1                 Age \<20         Both Null   5        3           0.8 (0.1--4.1)
  GSTT1 & GSTM1                 Age 20--24       No Null     10       21          Reference
  GSTT1 & GSTM1                 Age 20--24       Null in M   13       9           **3.0 (1.0--9.4)**
  GSTT1 & GSTM1                 Age 20--24       Null in T   2        8           NC
  GSTT1 & GSTM1                 Age 20--24       Both Null   1        4           NC
  GSTT1 & GSTM1                 Age 25+          No Null     8        45          Reference
  GSTT1 & GSTM1                 Age 25+          Null in M   7        27          1.5 (0.5--4.5)
  GSTT1 & GSTM1                 Age 25+          Null in T   1        7           NC
  GSTT1 & GSTM1                 Age 25+          Both Null   0        2           NC
  Vitamin use                                                                     
  MTHFR            rs1801133    Vitamin use      Wildtype    7        29          Reference
  MTHFR            rs1801133    Vitamin use      Hetero      22       28          **3.3 (1.2--8.8)**\*
  MTHFR            rs1801133    Vitamin use      Variant     4        11          1.5 (0.4--6.2)
  MTHFR            rs1801133    No vitamin use   Wildtype    9        12          Reference
  MTHFR            rs1801133    No vitamin use   Hetero      13       20          0.9 (0.3--2.6)
  MTHFR            rs1801133    No vitamin use   Variant     4        5           1.1 (0.2--5.1)
  NOS3             rs1036145    Vitamin use      Wildtype    22       28          Reference
  NOS3             rs1036145    Vitamin use      Hetero      7        36          **0.2 (0.1--0.7)**
  NOS3             rs1036145    Vitamin use      Variant     4        3           1.7 (0.3--8.4)
  NOS3             rs1036145    No vitamin use   Wildtype    16       19          Reference
  NOS3             rs1036145    No vitamin use   Hetero      7        14          0.6 (0.2--1.8)
  NOS3             rs1036145    No vitamin use   Variant     4        3           1.6 (0.3--8.1)
  NOS3             rs10277237   Vitamin use      Wildtype    8        26          Reference
  NOS3             rs10277237   Vitamin use      Hetero      10       25          1.3 (0.4--3.8)
  NOS3             rs10277237   Vitamin use      Variant     11       7           **5.1 (1.5--17.6)**
  NOS3             rs10277237   No vitamin use   Wildtype    7        12          Reference
  NOS3             rs10277237   No vitamin use   Hetero      9        15          1.0 (0.3--3.6)
  NOS3             rs10277237   No vitamin use   Variant     7        5           2.4 (0.5--10.5)
  AGT              rs699        Vitamin use      Wildtype    10       31          Reference
  AGT              rs699        Vitamin use      Hetero      17       20          **2.6 (1.0--6.9)**\*\*
  AGT              rs699        Vitamin use      Variant     5        16          1.0 (0.3--3.3)
  AGT              rs699        No vitamin use   Wildtype    13       14          Reference
  AGT              rs699        No vitamin use   Hetero      11       16          0.7 (0.3--2.2)
  AGT              rs699        No vitamin use   Variant     3        6           0.5 (0.1--2.6)
  ADD1             rs7678161    Vitamin use      Wildtype    17       24          Reference
  ADD1             rs7678161    Vitamin use      Hetero      5        32          **0.2 (0.1--0.7)**\*\*
  ADD1             rs7678161    Vitamin use      Variant     1        1           NC
  ADD1             rs7678161    No vitamin use   Wildtype    7        13          Reference
  ADD1             rs7678161    No vitamin use   Hetero      14       17          1.5 (0.5--4.9)
  ADD1             rs7678161    No vitamin use   Variant     1        1           NC
  ADD1             rs10026792   Vitamin use      Wildtype    26       48          Reference
  ADD1             rs10026792   Vitamin use      Hetero      6        18          0.6 (0.2--1.7)
  ADD1             rs10026792   Vitamin use      Variant     2        2           NC
  ADD1             rs10026792   No vitamin use   Wildtype    12       25          Reference
  ADD1             rs10026792   No vitamin use   Hetero      13       8           **3.4 (1.1--10.4)**\*\*
  ADD1             rs10026792   No vitamin use   Variant     1        2           NC
  ADD1             rs12503220   Vitamin use      Wildtype    18       53          Reference
  ADD1             rs12503220   Vitamin use      Hetero      14       12          **3.4 (1.3--8.8)**
  ADD1             rs12503220   Vitamin use      Variant     3        4           2.2 (0.5--10.8)
  ADD1             rs12503220   No vitamin use   Wildtype    13       25          Reference
  ADD1             rs12503220   No vitamin use   Hetero      13       10          2.5 (0.9--7.2)
  ADD1             rs12503220   No vitamin use   Variant     1        2           NC
  SCNN1A           rs2228576    Vitamin use      Wildtype    13       37          Reference
  SCNN1A           rs2228576    Vitamin use      Hetero      15       23          1.9 (0.7--4.6)
  SCNN1A           rs2228576    Vitamin use      Variant     5        5           2.8 (0.7--11.4)
  SCNN1A           rs2228576    No vitamin use   Wildtype    18       13          Reference
  SCNN1A           rs2228576    No vitamin use   Hetero      7        20          **0.3 (0.1--0.8)**\*\*
  SCNN1A           rs2228576    No vitamin use   Variant     2        4           NC
  GNB3             Rs5443       Vitamin use      Wildtype    24       26          Reference
  GNB3             Rs5443       Vitamin use      Hetero      5        31          **0.2 (0.1--0.5)**
  GNB3             Rs5443       Vitamin use      Variant     4        9           0.5 (0.1--1.8)
  GNB3             Rs5443       No vitamin use   Wildtype    19       17          Reference
  GNB3             Rs5443       No vitamin use   Hetero      5        13          0.3 (0.1--1.2)
  GNB3             Rs5443       No vitamin use   Variant     3        6           0.4 (0.1--2.1)
  ICAM1            rs281432     Vitamin use      Wildtype    13       18          Reference
  ICAM1            rs281432     Vitamin use      Hetero      8        33          **0.3 (0.1--1.0)**\*
  ICAM1            rs281432     Vitamin use      Variant     11       14          1.1 (0.4--3.2)
  ICAM1            rs281432     No vitamin use   Wildtype    10       18          Reference
  ICAM1            rs281432     No vitamin use   Hetero      11       9           2.2 (0.7--7.1)
  ICAM1            rs281432     No vitamin use   Variant     6        5           2.2 (0.5--8.9)
  ICAM1            rs3093030    Vitamin use      Wildtype    16       30          Reference
  ICAM1            rs3093030    Vitamin use      Hetero      6        13          0.9 (0.3--2.7)
  ICAM1            rs3093030    Vitamin use      Variant     8        9           1.7 (0.5--5.2)
  ICAM1            rs3093030    No vitamin use   Wildtype    10       23          Reference
  ICAM1            rs3093030    No vitamin use   Hetero      4        5           1.8 (0.4--8.3)
  ICAM1            rs3093030    No vitamin use   Variant     10       3           **7.7 (1.7--34.0)**
  ICAM4            rs281438     Vitamin use      Wildtype    22       45          Reference
  ICAM4            rs281438     Vitamin use      Hetero      6        19          0.6 (0.2--1.8)
  ICAM4            rs281438     Vitamin use      Variant     5        2           NC
  ICAM4            rs281438     No vitamin use   Wildtype    14       31          Reference
  ICAM4            rs281438     No vitamin use   Hetero      11       5           **4.9 (1.4--16.7)**\*\*
  ICAM4            rs281438     No vitamin use   Variant     2        1           NC
  ICAM5            rs281417     Vitamin use      Wildtype    9        22          Reference
  ICAM5            rs281417     Vitamin use      Hetero      14       29          1.2 (0.4--3.2)
  ICAM5            rs281417     Vitamin use      Variant     4        3           3.3 (0.6--17.6)
  ICAM5            rs281417     No vitamin use   Wildtype    4        22          Reference
  ICAM5            rs281417     No vitamin use   Hetero      11       5           **12.1 (2.7--54.3)**\*\*
  ICAM5            rs281417     No vitamin use   Variant     4        2           NC
  ICAM5            rs281440     Vitamin use      Wildtype    2        30          Reference
  ICAM5            rs281440     Vitamin use      Hetero      20       25          **12.0 (2.6--56.4)**
  ICAM5            rs281440     Vitamin use      Variant     3        4           **11.2 (1.4--89.2)**
  ICAM5            rs281440     No vitamin use   Wildtype    0        18          Reference
  ICAM5            rs281440     No vitamin use   Hetero      15       15          NC
  ICAM5            rs281440     No vitamin use   Variant     1        2           NC
  ICAM5            rs2075741    Vitamin use      Wildtype    11       23          Reference
  ICAM5            rs2075741    Vitamin use      Hetero      11       25          0.9 (0.3--2.5)
  ICAM5            rs2075741    Vitamin use      Variant     10       17          1.2 (0.4--3.6)
  ICAM5            rs2075741    No vitamin use   Wildtype    6        18          Reference
  ICAM5            rs2075741    No vitamin use   Hetero      9        11          2.5 (0.7--8.8)
  ICAM5            rs2075741    No vitamin use   Variant     12       7           **5.1 (1.4--19.1)**
  Smoking                                                                         
  NOS3             rs1036145    Smoking          Wildtype    6        8           Reference
  NOS3             rs1036145    Smoking          Hetero      3        7           0.6 (0.1--3.2)
  NOS3             rs1036145    Smoking          Variant     2        0           NC
  NOS3             rs1036145    No Smoking       Wildtype    33       39          Reference
  NOS3             rs1036145    No Smoking       Hetero      10       42          **0.3 (0.1--0.6)**
  NOS3             rs1036145    No Smoking       Variant     6        6           1.2 (0.3--4.0)
  NOS3             rs10277237   Smoking          Wildtype    4        9           Reference
  NOS3             rs10277237   Smoking          Hetero      3        3           2.2 (0.3--16.4)
  NOS3             rs10277237   Smoking          Variant     3        1           NC
  NOS3             rs10277237   No Smoking       Wildtype    11       29          Reference
  NOS3             rs10277237   No Smoking       Hetero      15       37          1.1 (0.4--2.7)
  NOS3             rs10277237   No Smoking       Variant     16       11          **3.8 (1.4--10.8)**
  NPPA             rs5065       Smoking          Wildtype    9        13          Reference
  NPPA             rs5065       Smoking          Hetero      3        2           NC
  NPPA             rs5065       Smoking          Variant     0        0           NC
  NPPA             rs5065       No Smoking       Wildtype    42       67          Reference
  NPPA             rs5065       No Smoking       Hetero      5        22          **0.4 (0.1--1.0)**\*
  NPPA             rs5065       No Smoking       Variant     1        0           NC
  ADD1             rs7678161    Smoking          Wildtype    3        6           Reference
  ADD1             rs7678161    Smoking          Hetero      7        7           2.0 (0.4--11.4)
  ADD1             rs7678161    Smoking          Variant     0        0           NC
  ADD1             rs7678161    No Smoking       Wildtype    22       31          Reference
  ADD1             rs7678161    No Smoking       Hetero      12       41          **0.4 (0.2--1.0)**\*
  ADD1             rs7678161    No Smoking       Variant     2        2           NC
  ADD1             rs12503220   Smoking          Wildtype    7        12          Reference
  ADD1             rs12503220   Smoking          Hetero      5        3           2.9 (0.5--15.8)
  ADD1             rs12503220   Smoking          Variant     0        0           NC
  ADD1             rs12503220   No Smoking       Wildtype    24       66          Reference
  ADD1             rs12503220   No Smoking       Hetero      22       18          **3.4 (1.5--7.3)**
  ADD1             rs12503220   No Smoking       Variant     4        6           1.8 (0.5--7.1)
  GNB3             Rs5443       Smoking          Wildtype    9        7           Reference
  GNB3             Rs5443       Smoking          Hetero      2        5           NC
  GNB3             Rs5443       Smoking          Variant     1        3           NC
  GNB3             Rs5443       No Smoking       Wildtype    34       36          Reference
  GNB3             Rs5443       No Smoking       Hetero      8        38          **0.2 (0.1--0.5)**
  GNB3             Rs5443       No Smoking       Variant     6        12          0.5 (0.2--1.6)
  ICAM5            rs281417     Smoking          Wildtype    2        7           Reference
  ICAM5            rs281417     Smoking          Hetero      4        4           NC
  ICAM5            rs281417     Smoking          Variant     2        2           NC
  ICAM5            rs281417     No Smoking       Wildtype    11       37          Reference
  ICAM5            rs281417     No Smoking       Hetero      21       30          **2.4 (1.0--5.6)**
  ICAM5            rs281417     No Smoking       Variant     5        3           **5.6 (1.2--27.3)**
  ICAM5            rs281440     Smoking          Wildtype    0        6           Reference
  ICAM5            rs281440     Smoking          Hetero      5        5           NC
  ICAM5            rs281440     Smoking          Variant     1        1           NC
  ICAM5            rs281440     No Smoking       Wildtype    1        41          Reference
  ICAM5            rs281440     No Smoking       Hetero      30       35          NC
  ICAM5            rs281440     No Smoking       Variant     3        5           NC

OR is bolded if confidence interval excludes 1.0 (if bolded estimate includes 1.0 it is due to rounding).

OR\* if *P*‐value of Wald chi‐squared test on interaction term \<0.2; \*\*\<0.1.

NC is not calculated because the number in the cells of either the estimate or referent are \<3.

© 2016 Wiley Periodicals, Inc.

The following gene variants were associated with increased risk of gastroschisis among mothers with no vitamin use: *ADD1* (rs10026792), *ICAM4* (rs281438), *ICAM5* (rs281417) and a decreased risk among mothers with vitamin use: *ADD1* (rs7678161), *ICAM1* (rs281432). There were also some results in the unexpected direction. Heterozygous variants of *MTHFR* (rs1801133) and *AGT* (rs699) were associated with increased risk among vitamin users and *SCNN1A* (rs2228576) was associated with decreased risk among non‐vitamin users.

The only significant results stratified by smoking were among non‐smokers. Owing to the low proportion of smokers, there was insufficient statistical power to reasonably estimate several ORs among smokers. A decreased risk of gastroschisis was observed among non‐smoking mothers whose infants were heterozygous for *ADD1* (rs7678161) and *NPPA* (rs5065).

Haplotype blocks were constructed using the HaploView program. In general, reconstruction of the SNPs did not show evidence of nonrandom association with gastroschisis (Table [IV](#ajmga37883-tbl-0004){ref-type="table-wrap"}), which may have been a function of small sample size.

###### 

Haplotype Associations With Risk of Gastroschisis in Cases and Non‐Malformed Controls, California 1997--2001

  Gene symbol             Haplotype   Frequency   Case, control ratio counts   OR (95% CI)[^\*^](#ajmga37883-note-0015){ref-type="fn"}
  ----------------------- ----------- ----------- ---------------------------- ---------------------------------------------------------
  All race/ethnicities                                                         
  ADD1                    TG          0.52        81.8:76.2, 156.1:141.9       1.0 (0.7--1.4)
  ADD1                    CG          0.29        46.7:111.3, 86.0:212.0       1.0 (0.7--1.6)
  ADD1                    CA          0.18        28.3:129.7, 55.7:242.3       0.9 (0.6--1.6)
  ADD1                    TA          0.003       1.2:156.8, 0.2:297.8         NC
  ICAM1                   TCA         0.44        71.7:84.3, 125.8:168.2       1.1 (0.8--1.7)
  ICAM1                   TTG         0.28        52.2:103.8, 74.9:219.1       1.5 (1.0--2.2)
  ICAM1                   ATG         0.14        17.2:138.8, 45.7:248.3       0.7 (0.4--1.2)
  ICAM1                   TCG         0.136       13.8:142.2, 47.3:246.7       0.5 (0.3--1.0)
  ICAM1                   ACA         0.003       1.1:154.9, 0.2:293.8         NC
  TNF                     CG          0.69        112.0:42.0, 198.0:96.0       1.3 (0.8--2.0)
  TNF                     AG          0.228       31.0:123.0, 71.0:223.0       0.8 (0.5--1.3)
  TNF                     AA          0.08        11.0:143.0, 25.0:269.0       0.8 (0.4--1.7)
  NOS3                    GC          0.765       118.9:35.1, 223.8:70.2       1.1 (0.7--1.7)
  NOS3                    CT          0.229       34.9:119.1, 67.7:226.3       1.0 (0.6--1.6)
  NOS3                    CC          0.003       0.1:153.9, 1.2:292.8         NC
  NOS3                    GT          0.003       0.1:153.9, 1.2:292.8         NC
  White                                                                        
  ICAM1                   TCA         0.489       32.2:27.8, 48.0:56.0         1.4 (0.7--2.6)
  ICAM1                   TTG         0.198       14.5:45.5, 18.0:86.0         1.5 (0.7--3.3)
  ICAM1                   ATG         0.17        8.0:52.0, 20.0:84.0          0.6 (0.3--1.6)
  ICAM1                   TCG         0.14        5.3:54.7, 18.0:86.0          0.5 (0.2--1.3)
  NPPA                    GA          0.854       53.0:7.0, 87.0:17.0          1.5 (0.6--3.8)
  NPPA                    AG          0.11        7.0:53.0, 11.0: 93.0         1.1 (0.4--3.1)
  NPPA                    GG          0.037       0.0:60.0, 6.0:98.0           NC
  NOS3                    GC          0.705       44.0:14.0, 68.9:33.1         1.5 (0.7--3.1)
  NOS3                    CT          0.279       14.0:44.0, 30.7:71.3         0.7 (0.4--1.5)
  NOS3                    CC          0.008       0.0:58.0, 1.3:100.7          NC
  NOS3                    GT          0.007       0.0:58.0, 1.2:100.8          NC
  Native‐born Hispanic                                                         
  ICAM1                   TG          0.44        16.8:23.2, 23.8:28.2         0.9 (0.4--2.0)
  ICAM1                   CA          0.41        17.0:23.0, 21.0:31.0         1.1 (0.5--2.5)
  ICAM1                   CG          0.147       6.2:33.8, 7.2:44.8           1.1 (0.4--3.7)
  ICAM5                   CC          0.510       21.0:21.0, 28.0:26.0         0.9 (0.4--2.1)
  ICAM5                   GT          0.408       18.7:23.3, 20.5:33.5         1.3 (0.6--3.0)
  ICAM5                   CT          0.082       2.3:39.7, 5.5:48.5           0.5 (0.1--2.5)
  NOS3                    GC          0.702       28.0:14.0, 38.0:14.0         0.7 (0.3--1.8)
  NOS3                    CT          0.298       14.0:28.0, 14.0:38.0         1.4 (0.6--3.3)
  NOS3                    GA          0.696       26.9:15.1, 39.9:14.1         0.6 (0.3--1.5)
  NOS3                    TG          0.270       13.9:28.1, 12.0:42.0         1.7 (0.7--4.3)
  NOS3                    TA          0.022       0.1:41.9, 2.1:51.9           0.1 (0.0--33.9)
  NOS3                    GG          0.011       1.1:40.9, 0.0:54.0           NC
  Foreign‐born Hispanic                                                        
  ICAM1                   TG          0.499       21.8:16.2, 39.0:45.0         1.6 (0.7--3.4)
  ICAM1                   CA          0.392       14.8:23.2, 33.0:51.0         1.0 (0.4--2.2)
  ICAM1                   CG          0.110       1.4:36.6, 12.0:72.0          0.2 (0.0--1.4)
  NOS3                    GC          0.844       32.0:4.0, 71.0:15.0          1.7 (0.5--5.5)
  NOS3                    CT          0.156       4.0:32.0, 15.0:71.0          0.6 (0.2--1.9)

All race/ethnicities: ADD1 included rs3775068, rs10026792; ICAM1 included rs1059840, rs11115, rs1059849; TNF included rs1041981, rs1800629; NOS3 included rs2373962, rs6951150.

White: ICAM1 included rs1059840, rs11115, rs1059849; NPPA included rs198372, rs198373; NOS3 included rs2373962, rs6951150.

Native‐born Hispanic: ICAM1 included rs11115, rs1059849; ICAM5 included rs2075741, rs2569702; NOS3 included rs2373962, rs6951150, rs4496877, rs1800779.

Foreign‐born Hispanic: ICAM1 included rs11115, rs1059849; NOS3 included rs2373962, rs6951150.

NC is not calculated because one of the case, control ratio counts is 0.

ORs are not calculated where the estimate in the frequency is \<0.01.

© 2016 Wiley Periodicals, Inc.

DISCUSSION {#ajmga37883-sec-0008}
==========

This California population‐based study observed increased risks of gastroschisis for infants who had variants in genes related to blood pressure and cell--cell interaction. Homozygous and heterozygous variants of two genes related to blood pressure (*NOS3* and *ADD1*), were associated with increased risks of gastroschisis. Several homozygous and heterozygous variants in the cell--cell interaction patho‐genetic grouping were associated with increased risks of gastroschisis. *ICAM1*, *ICAM4*, and several *ICAM5* variants significant associations with gastroschisis, including one *ICAM5* variant with a strong, but statistically limited association. Additionally, variants of *GNB3* and *NAT1* showed decreased risk for gastroschisis.

In a previous California study of selected births between 1988--1990, which investigated many of the same genes and variants, Torfs et al. \[[2006](#ajmga37883-bib-0023){ref-type="ref"}\] found the following gene variants associated with increased risk for gastroschisis: heterozygotes in *ICAM1* (rs1799969), *NOS3* (rs1799983), *NPPA* (rs5065), and *ADD1* (rs4961). Additionally, for *NPPA* and *ADD1*, homozygote variants were associated with higher risk than the heterozygotes \[Torfs et al., [2006](#ajmga37883-bib-0023){ref-type="ref"}\]. The results of the specific variants were not confirmed by the current study; however, the both studies found associations with the same patho‐genetic groupings.

In the current study, tests of effect modification revealed interactions between folic acid‐containing vitamin use and several *ICAM* and *ADD1* gene variants in infants indicating a protective effect of vitamin use in the context of these variants. Conversely, SCNN1A, MTHFR, ADD1, and AGT variants were associated with either decreased risk with no vitamin use or increased risk with vitamin use. When stratified by age groups, four *NOS3* gene variants were associated with gastroschisis among women aged 20--24. ADD1 variants were associated with gastroschisis among women over 25. None of the investigated gene variants seemed to be associated with greater frequency among gastroschisis infants whose mothers were teenagers.

We did not identify an interaction among women who smoked during the peri‐conceptional period, but the study population had too few smokers to adequately estimate possible effect modification. We did find a decreased risk of gastroschisis among non‐smokers with variants of NPPA and ADD1. A previous study a decade earlier in the same geographic area, found interactions between maternal smoking and *NOS3*, *ICAM1*, and *NPPA* \[Torfs et al., [2006](#ajmga37883-bib-0023){ref-type="ref"}\]. These inconsistent results may be attributable to a decrease in the smoking rate among pregnant mothers between 1988--1990 and 1997--2001 \[Torfs et al., [2006](#ajmga37883-bib-0023){ref-type="ref"}\].

Among genes with variants we showed to be associated with gastroschisis, those related to blood pressure may be potential candidates for future studies owing to the hypothesis that this phenotype has an underlying pathogenesis associated with vascular disruption \[Feldkamp et al., [2007](#ajmga37883-bib-0009){ref-type="ref"}\]. Previous studies corroborate the biologic mechanism by which *NOS3* and *ADD1* may be associated with gastroschisis. The *NOS3* gene has been hypothesized to be associated with gastroschisis \[Lammer et al., [2008](#ajmga37883-bib-0014){ref-type="ref"}\]. When *NOS3* is activated, it translocates into the cytosol, where it can convert arginine to nitric oxide (NO), which plays important physiological roles as a mediator of vascular tone. *NOS3* also contributes crucial roles in regulating endothelial migration, angiogenesis, and vascular remodeling \[Murohara et al., [1998](#ajmga37883-bib-0016){ref-type="ref"}; Rudic et al., [1998](#ajmga37883-bib-0022){ref-type="ref"}; Aicher et al., [2003](#ajmga37883-bib-0002){ref-type="ref"}; Ahmad et al., [2006](#ajmga37883-bib-0001){ref-type="ref"}\]. NO seems to function as a maintenance factor for several integrins that are important regulators of cell migration and angiogenesis \[Murohara et al., [1999](#ajmga37883-bib-0017){ref-type="ref"}; Lee et al., [2000](#ajmga37883-bib-0015){ref-type="ref"}\]. These processes are likely important to the development of gastroschisis, whose pathogenesis may be linked to vascular disruption---but the pathogenesis remains uncertain, in part because of the absence of spontaneously occurring gastroschisis among experimental animal models, like mice. Additionally, *ADD1* is important in epidermal differentiation, cell proliferation and wound repair \[Guo et al., [2005](#ajmga37883-bib-0010){ref-type="ref"}\].

*ICAM* is another gene that has been hypothesized to be associated with gastroschisis and is related to cell--cell interaction. *ICAM1* is linked to nitric oxide production and control over vascular remodeling. Cell adhesion molecules are important for the coordinated regulation of endothelial cell migration during angiogenesis. *ICAMs* are a family of cell surface proteins including a subset that is encoded by three genes (*ICAM1*, 4--5) clustered at chromosome *19p32* \[Hayflick et al., [1998](#ajmga37883-bib-0011){ref-type="ref"}\]. Each *ICAM* binds a LFA‐1 ligand and perhaps other ligands, providing essential adhesion signals. Recent experiments have shown that endothelial cell adhesion molecules are likely to be involved in angiogenesis \[Lammer et al., [2008](#ajmga37883-bib-0014){ref-type="ref"}\].

Our study has several strengths including its population‐based design, complete case ascertainment by a well‐established active birth defects monitoring program and detailed information on critical covariates such as vitamin use and exposure to active and passive cigarette smoke. We investigated a large number of gene variants involved in several biologically relevant pathways, that is, homocysteine metabolism, blood pressure regulation, coagulation, cell--cell interaction, and inflammatory response. Notably, we were able to evaluate genetic risks of gastroschisis in combination with important covariates including age, race/ethnicity, vitamin use and smoking, and risk of gastroschisis. Given the relatively recent increase in gastroschisis (decades), it does not seem likely that gastroschisis would have a sole genetic etiology, but rather an etiology explained by gene‐environment interaction.

Our results need to be considered relative to some limitations as well. Sample sizes for many comparisons were modest contributing to imprecision in potential risk estimation. Our study was limited to the infant genotype information. Thus, we were unable to investigate the effect of the maternal genotype. As with any study that seeks to explore associations with a large number of genotypes, findings are subject to chance owing to multiple comparisons. Further, the selected gene variants represent only a fraction of the potential variation of the studied genes.

Our study rigorously adds to the scant literature on this topic and provides further information on candidate genes for future studies. Specifically, *NOS3*, *ADD1*, and *ICAM* warrant further investigation in additional populations, ideally larger, and with the interaction of additional environmental exposures.
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**Table SI**. Associations between gene variants and risk of gastroschisis in cases and non‐malformed controls, California 1997--2001.

###### 

Click here for additional data file.
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